ORA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ormat Technologies Inc (ORA) is not a strong buy at the moment for a beginner investor with a long-term horizon. While the company has strong potential in geothermal energy and analysts generally maintain positive ratings, the recent financial performance shows declining net income, EPS, and gross margin, which raises concerns. Additionally, technical indicators do not signal a clear entry point, and no strong trading signals (AI Stock Picker or SwingMax) are present. The options data suggests a neutral to slightly bullish sentiment, but the lack of significant positive catalysts and the current pre-market price movement do not justify an immediate buy decision.
The MACD histogram is negative (-1.37) but contracting, indicating bearish momentum is weakening. RSI is neutral at 36.735, and moving averages are converging, suggesting no clear trend. The stock is trading near its support level (S1: 103.081) but below the pivot point (110.243), indicating limited upward momentum.
and RBC ($
reflect confidence in the company's long-term potential.
Financial performance in Q4 2025 showed a decline in net income (-23.19%), EPS (-23.88%), and gross margin (-10.41%), raising concerns about profitability. Additionally, the company's guidance reflects slower-than-expected growth in its Electricity segment. Technical indicators do not suggest a strong upward trend, and no significant insider or hedge fund activity has been observed.
In Q4 2025, revenue increased by 19.63% YoY to $276.036 million, driven by strength in the Product and Storage segments. However, net income dropped to $31.353 million (-23.19% YoY), and EPS fell to 0.51 (-23.88% YoY). Gross margin also declined to 28.56% (-10.41% YoY), indicating margin compression and profitability challenges.
Analysts generally maintain positive ratings, with RBC initiating coverage with an Outperform rating and a $130 price target. UBS, Barclays, and others have also issued Buy or Overweight ratings with price targets ranging from $123 to $143. However, some analysts, like JPMorgan, have expressed concerns about valuation and slower growth in certain segments.
